CVS Caremark To Pay FTC $5 Million To Resolve First Medicare Part D Deceptive Pricing Case
This article was originally published in The Pink Sheet Daily
Executive Summary
The Federal Trade Commission claims a CVS subsidiary posted prices for Rx drugs at CVS and Walgreens pharmacies that were as much as ten times less than the actual prices, pushing consumers into the donut hole more quickly.